Reviva Pharmaceuticals Holdings Inc (RVPH): dilution...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: vein post# 12

Monday, 01/10/2022 7:16:06 PM

Monday, January 10, 2022 7:16:06 PM

dilution...

Keep Last Read

Replies (2) Next 10 Prev Next

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:32:46 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:15 AM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/13/2024 10:00:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 09:38:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:15 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/17/2023 09:03:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:12:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 12:20:19 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/04/2023 09:03:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:02:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/17/2023 10:30:33 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:16:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:15:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:16:19 PM

InvestorsHub NewsWire

Only $200 per official company press release!